Frkjr-Jensen C, Davis MW, Sarov M, Taylor J, Flibotte S, LaBella M, et al
BYDUREON versus Liraglutide, Both as Add-on to Metformin, a Sulfonylurea, Metformin + Sulfonylurea, or Metformin + Pioglitazone Therapy A 26-week open-label comparator-controlled trial was conducted to compare the safety and efficacy of BYDUREON to liraglutide in patients with type 2 diabetes whose glycemic control was inadequate with metformin, a sulfonylurea, metformin plus sulfonylurea, or metformin plus pioglitazone therapy (Trial 6 - NCT01029886)
Zeng Y, Wu R, Wang F, Li S, Li L, Li Y, et al
Since knowledge is power, especially when it comes to your health, weve broken down the science, weight-loss stats, and side effects for each of these wonder drugs
15, Issue 2, Article 66).